Further, using the cutoff value of 15 ng/ml, circulating STAT3 could be a sensitive biomarker to predict the development of MALEs in patients with PAD (HR: 0.35, CI: 0.19–0.63, p = 0.001). This evidence concerns the gene STAT3 and peripheral arterial disease.